Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

References

• Lee JC. The prospects for developing a vaccine against Staphylococcus aureus. Trends Microbiol 1996; 4:162 - 6; http://dx.doi.org/10.1016/0966-842X(96)10021-4; PMID: 8728611
   PubMed Web of Science ®Google Scholar
• Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines 2008; 7:805 - 15; http://dx.doi.org/10.1586/14760584.7.6.805; PMID: 18665778
   PubMed Web of Science ®Google Scholar
• Otto M. Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies. BioDrugs 2008; 22:27 - 36; http://dx.doi.org/10.2165/00063030-200822010-00003; PMID: 18215088
   PubMed Web of Science ®Google Scholar
• Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 2008; 32:Suppl 1 S71 - 8; http://dx.doi.org/10.1016/j.ijantimicag.2008.06.009; PMID: 18757184
   PubMed Web of Science ®Google Scholar
• Cunnion KM, Benjamin DK Jr., Hester CG, Frank MM. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia. J Lab Clin Med 2004; 143:358 - 65; http://dx.doi.org/10.1016/j.lab.2004.03.005; PMID: 15192652
   PubMedGoogle Scholar
• Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996; 157:2514 - 20; PMID: 8805652
   PubMed Web of Science ®Google Scholar
• Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997; 65:2517 - 21; PMID: 9199413
   PubMed Web of Science ®Google Scholar
• Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Douglas SD, Quie PG, et al. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest 1978; 61:597 - 609; http://dx.doi.org/10.1172/JCI108971; PMID: 641141
   PubMed Web of Science ®Google Scholar
• Verbrugh HA, Peterson PK, Nguyen BYT, Sisson SP, Kim Y. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J Immunol 1982; 129:1681 - 7; PMID: 7108223
   PubMed Web of Science ®Google Scholar
• Leijh PCJ, van den Barselaar MT, Daha MR, van Furth R. Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun 1981; 33:714 - 24; PMID: 7026443
   PubMed Web of Science ®Google Scholar
• Anwar S, Prince LR, Foster SJ, Whyte MKB, Sabroe I. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol 2009; 157:216 - 24; http://dx.doi.org/10.1111/j.1365-2249.2009.03950.x; PMID: 19604261
   PubMed Web of Science ®Google Scholar
• Robertson CM, Perrone EE, McConnell KW, Dunne WM, Boody B, Brahmbhatt T, et al. Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res 2008; 150:278 - 85; http://dx.doi.org/10.1016/j.jss.2008.02.009; PMID: 18621398
   PubMed Web of Science ®Google Scholar
• Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Saïd-Salim B, Porcella SF, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907 - 19; PMID: 16148137
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS, Yeaman MR, Lin L, Fu Y, Avanesian V, et al. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 2008; 76:4574 - 80; http://dx.doi.org/10.1128/IAI.00700-08; PMID: 18644876
   PubMed Web of Science ®Google Scholar
• Gjertsson I, Hultgren OH, Stenson M, Holmdahl R, Tarkowski A. Are B lymphocytes of importance in severe Staphylococcus aureus infections?. Infect Immun 2000; 68:2431 - 4; http://dx.doi.org/10.1128/IAI.68.5.2431-2434.2000; PMID: 10768927
   PubMed Web of Science ®Google Scholar
• Gjertsson I, Nitschke L, Tarkowski A. The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis. Microbes Infect 2004; 6:377 - 82; http://dx.doi.org/10.1016/j.micinf.2003.12.013; PMID: 15050965
   PubMed Web of Science ®Google Scholar
• Zhao Y, Abdelnour A, Holmdahl R, Tarkowski A, Th International Congress of Immunology. The XID defect provides protection against Staphylococcus aureus-induced arthritis. J Immunol 1995; 155:2067 - 76; PMID: 7636257
   PubMed Web of Science ®Google Scholar
• Sasaki S, Nishikawa S, Miura T, Mizuki M, Yamada K, Madarame H, et al. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect Immun 2000; 68:2424 - 30; http://dx.doi.org/10.1128/IAI.68.5.2424-2430.2000; PMID: 10768926
   PubMed Web of Science ®Google Scholar
• Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009; 5:e1000703; http://dx.doi.org/10.1371/journal.ppat.1000703; PMID: 20041174
   PubMed Web of Science ®Google Scholar
• McLoughlin RM, Solinga RM, Rich J, Zaleski KJ, Cocchiaro JL, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A 2006; 103:10408 - 13; http://dx.doi.org/10.1073/pnas.0508961103; PMID: 16801559
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57 - 79; http://dx.doi.org/10.1111/j.1600-065X.2008.00699.x; PMID: 19161416
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206:1291 - 301; http://dx.doi.org/10.1084/jem.20082767; PMID: 19487419
   PubMed Web of Science ®Google Scholar
• Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011; 3:129 - 41; http://dx.doi.org/10.1002/emmm.201000115; PMID: 21268281
   PubMed Web of Science ®Google Scholar
• Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009; 31:799 - 810; http://dx.doi.org/10.1016/j.immuni.2009.08.025; PMID: 19853481
   PubMed Web of Science ®Google Scholar
• Roche FM, Massey R, Peacock SJ, Day NPJ, Visai L, Speziale P, et al. Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology 2003; 149:643 - 54; http://dx.doi.org/10.1099/mic.0.25996-0; PMID: 12634333
   PubMed Web of Science ®Google Scholar
• Morrissey JA, Cockayne A, Hammacott J, Bishop K, Denman-Johnson A, Hill PJ, et al. Conservation, surface exposure, and in vivo expression of the Frp family of iron-regulated cell wall proteins in Staphylococcus aureus. Infect Immun 2002; 70:2399 - 407; http://dx.doi.org/10.1128/IAI.70.5.2399-2407.2002; PMID: 11953376
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 2003; 299:906 - 9; http://dx.doi.org/10.1126/science.1081147; PMID: 12574635
   PubMed Web of Science ®Google Scholar
• Brown M, Kowalski R, Zorman J, Wang XM, Towne V, Zhao QJ, et al. Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo. Clin Vaccine Immunol 2009; 16:1095 - 104; http://dx.doi.org/10.1128/CVI.00085-09; PMID: 19553551
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520 - 32; http://dx.doi.org/10.1056/NEJM199808203390806; PMID: 9709046
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 2006; 74:2215 - 23; http://dx.doi.org/10.1128/IAI.74.4.2215-2223.2006; PMID: 16552052
   PubMed Web of Science ®Google Scholar
• Ebert T, Smith S, Pancari G, Clark D, Hampton R, Secore S, et al. A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Hum Antibodies 2010; 19:113 - 28; PMID: 21178283
   PubMedGoogle Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8:950 - 7; http://dx.doi.org/10.1038/ni1497; PMID: 17676044
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821 - 52; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141557; PMID: 17201677
   PubMed Web of Science ®Google Scholar
• Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010; 159:109 - 19; http://dx.doi.org/10.1111/j.1365-2249.2009.04037.x; PMID: 19912252
   PubMed Web of Science ®Google Scholar
• Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, et al. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 2005; 12:387 - 98; PMID: 15753252
   PubMedGoogle Scholar
• Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Verbrugh HA, Jaddoe VWV, et al. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect 2010; 16:1312 - 7; http://dx.doi.org/10.1111/j.1469-0691.2009.03073.x; PMID: 19832714
   PubMed Web of Science ®Google Scholar
• Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, et al. Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 2010; 50:61 - 8; http://dx.doi.org/10.1086/648673; PMID: 19947854
   PubMed Web of Science ®Google Scholar
• Verkaik NJ, Boelens HA, de Vogel CP, Tavakol M, Bode LGM, Verbrugh HA, et al. Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2010; 29:509 - 18; http://dx.doi.org/10.1007/s10096-010-0888-0; PMID: 20186449
   PubMed Web of Science ®Google Scholar
• Colque-Navarro P, Palma M, Söderquist B, Flock JI, Möllby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol 2000; 7:14 - 20; PMID: 10618270
   PubMedGoogle Scholar
• Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, et al. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 2010; 120:3220 - 33; http://dx.doi.org/10.1172/JCI42748; PMID: 20739753
   PubMed Web of Science ®Google Scholar
• Malley R. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. Journal of Molecular Medicine (Berlin) 2010; 88
   PubMed Web of Science ®Google Scholar
• Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009; 119:1899 - 909; PMID: 19509469
   PubMed Web of Science ®Google Scholar
• McCool TL, Weiser JN. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun 2004; 72:5807 - 13; http://dx.doi.org/10.1128/IAI.72.10.5807-5813.2004; PMID: 15385481
   PubMed Web of Science ®Google Scholar
• Flach CF, Östberg AK, Nilsson AT, Malefyt RdeW, Raghavan S. Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect Immun 2011; 79:879 - 86; http://dx.doi.org/10.1128/IAI.00756-10; PMID: 21078851
   PubMed Web of Science ®Google Scholar
• Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998; 188:2277 - 88; http://dx.doi.org/10.1084/jem.188.12.2277; PMID: 9858514
   PubMed Web of Science ®Google Scholar
• Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692 - 702; http://dx.doi.org/10.1056/NEJM199903043400904; PMID: 10053178
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773 - 6; http://dx.doi.org/10.1038/nature06764; PMID: 18337720
   PubMed Web of Science ®Google Scholar
• Ma CS, Chew GYJ, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008; 205:1551 - 7; http://dx.doi.org/10.1084/jem.20080218; PMID: 18591410
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol 2009; 21:105 - 12; http://dx.doi.org/10.1093/intimm/dxn134; PMID: 19088064
   PubMed Web of Science ®Google Scholar
• Fischer A. Human immunodeficiency: connecting STAT3, Th17 and human mucosal immunity. Immunol Cell Biol 2008; 86:549 - 51; http://dx.doi.org/10.1038/icb.2008.52; PMID: 18645579
   PubMed Web of Science ®Google Scholar
• Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Immun 2010; 78:32 - 8; http://dx.doi.org/10.1128/IAI.00929-09; PMID: 19901061
   PubMed Web of Science ®Google Scholar
• Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010; 207:291 - 7; http://dx.doi.org/10.1084/jem.20091983; PMID: 20123958
   PubMed Web of Science ®Google Scholar
• Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011; 332:65 - 8; http://dx.doi.org/10.1126/science.1200439; PMID: 21350122
   PubMed Web of Science ®Google Scholar
• Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30:108 - 19; http://dx.doi.org/10.1016/j.immuni.2008.11.009; PMID: 19144317
   PubMed Web of Science ®Google Scholar
• Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120:1762 - 73; http://dx.doi.org/10.1172/JCI40891; PMID: 20364087
   PubMed Web of Science ®Google Scholar
• Kim HK, DeDent A, Cheng AG, McAdow M, Bagnoli F, Missiakas DM, et al. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 2010; 28:6382 - 92; http://dx.doi.org/10.1016/j.vaccine.2010.02.097; PMID: 20226248
   PubMed Web of Science ®Google Scholar
• Markham RB, Pier GB, Schreiber JR. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa. J Immunol 1991; 146:316 - 20; PMID: 1898604
   PubMed Web of Science ®Google Scholar
• Culkin SJ, Rhinehart-Jones T, Elkins KL. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 1997; 158:3277 - 84; PMID: 9120284
   PubMed Web of Science ®Google Scholar
• Lin L, Ibrahim AS, Baquir B, Avanesian V, Fu Y, Spellberg B. Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus. FEMS Immunol Med Microbiol 2009; 55:293 - 5; http://dx.doi.org/10.1111/j.1574-695X.2008.00531.x; PMID: 19159425
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348 - 57; PMID: 2419430
   PubMed Web of Science ®Google Scholar
• Spellberg B, Daum R. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men. Hum Vaccin 2010; 6:857 - 9; http://dx.doi.org/10.4161/hv.6.10.12469; PMID: 20930569
   PubMed Web of Science ®Google Scholar
• Fattom AI, Sarwar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 1996; 64:1659 - 65; PMID: 8613375
   PubMed Web of Science ®Google Scholar
• Fattom AI, Horwith G, Fuller S, Propst M, Naso R. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine 2004; 22:880 - 7; http://dx.doi.org/10.1016/j.vaccine.2003.11.034; PMID: 15040941
   PubMed Web of Science ®Google Scholar
• Cook J, Hepler R, Pancari G, Kuklin N, Fan HX, Wang XM, et al. Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection. Hum Vaccin 2009; 5:254 - 63; http://dx.doi.org/10.4161/hv.5.4.6765; PMID: 18787395
   PubMed Web of Science ®Google Scholar
• Patti JM. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine 2004; 22:Suppl 1 S39 - 43; http://dx.doi.org/10.1016/j.vaccine.2004.08.015; PMID: 15576200
   PubMedGoogle Scholar
• Vernachio JH, Bayer AS, Ames B, Bryant D, Prater BD, Syribeys PJ, et al. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob Agents Chemother 2006; 50:511 - 8; http://dx.doi.org/10.1128/AAC.50.2.511-518.2006; PMID: 16436704
   PubMed Web of Science ®Google Scholar
• Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, Chapman C, et al. Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun 2000; 68:3200 - 9; http://dx.doi.org/10.1128/IAI.68.6.3200-3209.2000; PMID: 10816464
   PubMed Web of Science ®Google Scholar
• Rupp ME, Holley HP Jr., Lutz J, Dicpinigaitis PV, Woods CW, Levine DP, et al. Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2007; 51:4249 - 54; http://dx.doi.org/10.1128/AAC.00570-07; PMID: 17893153
   PubMed Web of Science ®Google Scholar
• DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007; 151:260 - 5, 265, e1; http://dx.doi.org/10.1016/j.jpeds.2007.04.060; PMID: 17719934
   PubMed Web of Science ®Google Scholar
• Weems JJ Jr., Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, et al. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006; 50:2751 - 5; http://dx.doi.org/10.1128/AAC.00096-06; PMID: 16870768
   PubMed Web of Science ®Google Scholar
• Chao CC, Chen SJ, Adamopoulos IE, Davis N, Hong K, Vu A, et al. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 2011; 44:243 - 52; http://dx.doi.org/10.3109/08916934.2010.517815; PMID: 20925596
   PubMed Web of Science ®Google Scholar